ESC Webinar Series - Diabetes. Focus on the evidence for SGLT2i in the prevention and treatment of heart failure. SGLT2i – A new class of drugs for the treatment of heart failure.
Session HFA Webinars 2020
Event : Webinar 2020
- Topic : preventive cardiology
- Sub-topic : Diabetes and the Heart
- Date : 03 December 2020
- Session type : Webinar
- Supported by AstraZeneca as well as Boehringer Ingelheim and Lilly Alliance as an educational grant.